Zhibin Zhao

5PUBLICATIONS
38CO-AUTHORS
Molecular targetsCellular immunologyCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 05, 2026
Membranolytic peptide programs immunogenic cell death for cancer therapy.

|Dec 10, 2025
Autophagy of Kupffer cells modulates CD8+ T cell activation in primary biliary cholangitis.

Pan-Yue Luo, Min Ma, Meng-Chu Liu

|Oct 31, 2024
The AKR1C1-CYP1B1-cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma.

Chang Liu, Cheng Zhang, Hongkun Wu

|Apr 05, 2024
Targeting pathogenic CD8+ tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis.

Hao-Xian Zhu, Shu-Han Yang, Cai-Yue Gao

|Jun 16, 2023
Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer.

Fei Wang, Jie Long, Liang Li

Pageof 1

Frequent Collaborators

4 joint publications

Zhexiong Lian

2 joint publications

Liang Li

2 joint publications

Ying Han

2 joint publications

Merrill Eric Gershwin